Contingent liabilities explained

What a contingent liability is

A contingent liability is a potential obligation whose existence depends on a future event that is uncertain — a court ruling, a regulatory fine, a warranty claim spike, or a guarantee call. Unlike ordinary payables with fixed invoices, the amount and timing may be unknown when you read the 10-K.

Accounting rules split contingencies into buckets by probability and estimability:

• Probable and reasonably estimable — record a liability on the balance sheet (often within accrued liabilities or a dedicated reserve line) and expense the income statement in the period of recognition.
• Reasonably possible — do not accrue; disclose the nature of the contingency and an estimate or range of loss if one can be made.
• Remote — generally no disclosure required (unless material in rare cases).

The judgment words matter. “Probable” under ASC 450 means likely to occur — a higher bar than colloquial “possible.” Management teams and auditors debate these labels every quarter; investors should read changes in wording as signals, not boilerplate.

Balance sheet accrual vs footnote disclosure

When a loss is probable and estimable, the journal entry is straightforward:

• Debit: litigation expense (or warranty expense, environmental remediation, etc.)
• Credit: accrued liability / reserve

Cash outflow happens later at settlement. If new facts make the reserve too low, management increases the accrual and takes another expense hit. If the case resolves favorably, the company may reverse unused reserves into income — a common source of one-time earnings boosts that earnings-quality screens flag.

When a loss is only reasonably possible, nothing appears on the face of the balance sheet. The risk lives in Commitments and Contingencies footnotes — exactly where Harbor MedTech’s $210 million exposure hid. Enterprise value and credit models that stop at reported debt miss this layer unless analysts add probability-weighted scenarios.

Common categories investors should map

Product liability and class actions

Medical devices, autos, chemicals, and consumer products often carry long-tail claim inventories. Watch claim counts, venue concentration, insurance coverage limits, and whether reserves are per-case or actuarial. A flat reserve balance while pending claims rise is a yellow flag.

Warranty and recall obligations

Manufacturers accrue warranty reserves as a percentage of revenue or units shipped. A recall may start as a contingent disclosure and flip to a probable accrual within a quarter. Pair with COGS margin trends to see if remediation costs are eating gross profit beyond the reserve line.

Environmental remediation and regulatory fines

Superfund sites, pipeline spills, and EPA consent decrees can create multi-decade liabilities. Discounting and inflation assumptions in NPV models move the needle. Regulatory investigations (SEC, DOJ, FTC) may be disclosed before a fine is probable.

Guarantees, indemnities, and off-balance-sheet commitments

Parent guarantees of subsidiary debt, indemnities in M&A deals, and take-or-pay contracts can become contingent liabilities when trigger events occur. Read guarantee footnotes alongside lease and debt schedules for a full obligation stack.

Tax disputes and transfer-pricing audits

Uncertain tax positions under ASC 740 overlap with contingency thinking. A tax authority assessment may be probable but disputed; interest and penalties accrue separately. Cross-read deferred tax footnotes when audit reserves move.

Contingent liability roll-forward

Sophisticated filers present a roll-forward of litigation or warranty reserves each quarter:

• Beginning balance
• + Provisions (new expense accruals)
• − Payments (cash settlements)
• ± Reversals / adjustments (estimate changes)
• = Ending balance

For disclosed-but-unaccrued exposure, build a parallel table outside GAAP: assign probability weights (for example 25% on reasonably possible low end, 50% on midpoint scenarios) and sum to an expected loss overlay for valuation. This is not reported EPS; it is a risk-adjusted equity input.

Harbor MedTech’s refactor added three columns management had never shown together: accrued reserve, disclosed reasonably-possible range, and insurance recoveries (another contingent asset that nets against liability in economic terms). Once the overlay sat beside net debt in investor decks, the peer discount disappeared — the stock had been cheap for a reason.

Harbor MedTech refactor (worked example)

Pre-refactor consensus used:

• Enterprise value = equity + $85M net debt (no contingency overlay)
• 2026E EBITDA = $142M
• Implied multiple = 9.2x

Footnote 14 disclosed $22M accrued litigation reserve plus $140–210M reasonably possible unaccrued exposure on hip-fixation claims. Insurance carriers had accepted $40M of coverage on the discontinued line; recovery was probable but timing uncertain.

Analysts rebuilt:

• Base case liability overlay: $22M accrued + 30% × $175M midpoint unaccrued = $74.5M expected incremental loss
• Less probable insurance recovery: $40M × 80% = $32M
• Net contingent overlay: ~$42.5M (≈ 0.3× EBITDA)
• Adjusted net debt: $85M + $42.5M = $127.5M
• Adjusted EV/EBITDA: ~10.4x — in line with peers, not a deep discount

After the verdict, the overlay converged to actual settlement patterns and estimate errors fell from 44% to 10%. The lesson: contingent liabilities are not “off balance sheet” in an economic sense when footnotes quantify ranges.

Decision table: which lens to use

Common pitfalls

• Treating accrued reserves as the full story — reasonably possible disclosures can dwarf the balance sheet line.
• Ignoring wording changes — a shift from “possible” to “probable” often precedes a large one-time charge.
• Double-counting insurance — recoveries are contingent assets; net only when recovery is probable.
• Missing reversals — reserve releases inflate EPS; adjust for sustainable earnings.
• Using EV multiples without overlay — adds zero liability for footnote-only exposure.
• Discounting legal timelines incorrectly — mass torts can take a decade; NPV assumptions matter.
• Confusing contingencies with goodwill impairment — litigation hurts cash and reputation; impairment is a separate non-cash write-down test.

Investor checklist

• Read Commitments and Contingencies (and Legal Proceedings) in the 10-K and every 10-Q.
• Separate accrued reserves from reasonably possible ranges.
• Track quarter-over-quarter changes in claim counts, venues, and probability language.
• Build a reserve roll-forward; flag provisions far above payments for multiple quarters.
• Estimate probability-weighted overlay as % of EBITDA and market cap.
• Identify insurance coverage limits, deductibles, and counterparty credit.
• Stress-test equity with undiscounted high end of disclosed ranges.
• Check credit agreements for litigation thresholds and covenant carve-outs.
• Pair with cash flow: large settlements appear in operating or investing outflows when paid.
• Compare to accrued liabilities and financial statements for full liability stack context.

Key takeaways

• Contingent liabilities are uncertain obligations; recognition depends on probability and estimability under ASC 450 / IAS 37.
• Probable losses hit the balance sheet; reasonably possible losses often appear only in footnotes.
• Reported litigation reserves understate economic risk when large unaccrued ranges are disclosed.
• Roll-forwards and probability-weighted overlays reduce valuation dispersion.
• Harbor MedTech cut fair-value estimate errors from 44% to 10% by combining accrued reserves, disclosed ranges, and insurance recoveries.

Related reading

• Accrued liabilities explained — expense-before-cash accruals including litigation reserves
• SEC filings explained — where contingencies appear in 10-K and 10-Q footnotes
• Earnings quality explained — reserve releases, one-time charges, and accrual signals
• Financial statements explained — balance sheet, income statement, and cash flow links